Showing results (1571-1580 of 1,739) with videos related to

Sort By:
Pageof 174
Thyroid : Official Journal of the American Thyroid Association|October 1, 2014
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacementJacqueline Jonklaas, Antonio C Bianco, Andrew J Bauer, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 3, 2020
Targeted Oncogene Therapy Before Surgery in Pediatric Patients With Advanced Invasive Thyroid Cancer at Initial Presentation: Is It Time for a Paradigm Shift?Ken Kazahaya, Kara K Prickett, Vera A Paulson, et al.
British Journal of Cancer|January 1, 1997
Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III studyS Pyrhönen, R Valavaara, H Modig, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2018
Characteristics of Follicular Variant Papillary Thyroid Carcinoma in a Pediatric CohortStephanie L Samuels, Lea F Surrey, Colin P Hawkes, et al.
Biochemical Pharmacology|July 1, 2008
Development of XPA067.06, a potent high affinity human anti-gastrin monoclonal antibodySsucheng J Hsu, Amita Patel, Paul D Larsen, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2017
Perceived Autonomy Support in the NIMH RAISE Early Treatment ProgramJulia Browne, David L Penn, Daniel J Bauer, et al.
Journal of Alzheimer'S Disease : JAD|April 10, 2018
Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PETCynthia M Stonnington, Yinghua Chen, Cary R Savage, et al.
Current Research in Microbial Sciences|January 6, 2022
Genomic analysis of <i>Elizabethkingia</i> species from aquatic environments: Evidence for potential clinical transmissionSopheak Hem, Veronica M Jarocki, Dave J Baker, et al.
Human Molecular Genetics|January 19, 2010
Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signalingMadson Q Almeida, Michael Muchow, Sosipatros Boikos, et al.
Journal of Cutaneous Medicine and Surgery|April 30, 2003
Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of moderate to severe plaque psoriasisAlice B Gottlieb, Bruce Miller, Nicholas Lowe, et al.
Pageof 174